Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk …

Y Obayashi, M Natsuaki, H Watanabe… - European Heart …, 2024 - academic.oup.com
Background and aims High bleeding risk (HBR) and acute coronary syndrome (ACS)
subtypes are critical in determining bleeding and cardiovascular event risk after …
被引用次数：1 相关文章

Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk …

Y Obayashi, M Natsuaki, H Watanabe… - European Heart … - academic.oup.com
Methods and results In 4476 ACS patients enrolled in the STOPDAPT-3, where the no-
aspirin and dual antiplatelet therapy (DAPT) strategies after PCI were randomly compared …

Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk …

Y Obayashi, M Natsuaki, H Watanabe… - European Heart …, 2024 - europepmc.org
Methods In 4476 ACS patients enrolled in the STOPDAPT-3, where the no-aspirin and dual
antiplatelet therapy (DAPT) strategies after PCI were randomly compared, the pre-specified …

Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk …

Y Obayashi, M Natsuaki, H Watanabe… - European heart … - pubmed.ncbi.nlm.nih.gov
Background and aims High bleeding risk (HBR) and acute coronary syndrome (ACS)
subtypes are critical in determining bleeding and cardiovascular event risk after …